We are MultivisionDx

MICHAEL WITTINGER, PhD

Chief Executive Officer (CEO)

Michael has extensive leadership experience in developing and scaling high-growth companies in oncology, diagnostics, and regulated healthcare. He combines strategic vision with hands-on execution, guiding organizations through product development, commercialization, and international expansion. As CEO, he leads the company’s strategy, partnerships, and regulatory alignment.

KAROLINA PUNOVUORI, PhD

Chief Scientific Officer (CSO)

Karolina is an award-winning cancer researcher and scientific communicator who thrives on translating complex science into clinical impact. At MultivisionDx she steers the company’s scientific vision and strategy, and ensures that operations are running smoothly.

FABIEN BERTILLOT, PhD

Head of Computational Biology

Fabien leverages dual expertise in computational biology and cancer research to bring discoveries into the clinic. At MultivisionDx he leads data‑science operations and product development.

JÁNOS LENGYEL

Head of Engineering

Engineering visionary with deep expertise in software development, János drives the design and implementation of MultivisionDx’s technological backbone. He shapes the company’s product architecture and ensures robust, scalable solutions.

SARA WICKSTRÖM, MD, PhD

Science Advisor

Sara is Director of the Max Planck Institute for Molecular Biomedicine and a research director and principal investigator at University of Helsinki, and a medical doctor by training. She advises the company on scientific matters and leads a research collaboration between the company and University of Helsinki on clinical studies and biomarker development.